Lei L, Bhave M, Kalinsky K, Gandhi S, et al. Caution over haste: why novel endocrine therapy in early lines should wait in Estrogen receptor positive human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res 2026 Jan 22. doi: 10.1186/s13058-025-02203.
PMID: 41572375